Filter
201
Filtered Results: 201
Text search:
monoclonal
antibodies
Featured
Recommendations
33
New Publications
36
Language
Document type
No document type
81
Guidelines
56
Studies & Reports
23
Manuals
15
Fact sheets
11
Strategic & Response Plan
7
Resource Platforms
3
Training Material
2
Infographics
2
Situation Updates
1
Countries / Regions
India
15
Global
8
South Africa
6
Latin America and the Carribbean
5
Germany
5
Syria
3
Philippines
3
Venezuela
3
Congo, Democratic Republic of
3
Nigeria
2
Niger
2
Afghanistan
2
Africa
2
West and Central Africa
2
Middle East and North Africa
2
France
2
Spain
2
Russia
2
Mali
2
Indonesia
2
Pakistan
2
North Macedonia
1
Colombia
1
Mexico
1
Ukraine
1
El Salvador
1
Turkey
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Chile
1
Cameroon
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
USA
1
Haiti
1
Dominican Republic
1
Tanzania
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Western and Central Europe
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Uganda
1
Nicaragua
1
Brazil
1
Namibia
1
Egypt
1
Sudan
1
Yemen
1
Ethiopia
1
Honduras
1
Chad
1
Libya
1
Iraq
1
Somalia
1
Liberia
1
Ecuador
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
24
COVID-19
17
Vaccine-preventable Diseases
8
Drugs & Medical Equipment
6
Disease Prevention & Control
6
Virology
5
Rabies
4
Pediatrics
3
Policies & Guidelines HIV & TB
3
NTDs & Others
3
Non-communicable Diseases
3
Paediatrics
2
General Guidelines
2
Cancer Treatment & Resources
2
NCD
2
Hemorrhagic Fever
2
Diarrhoeal Disease/Cholera
2
Women & Child Health
2
Studies & Reports
2
Respiratory Infections
2
Immunization
2
Parasitology
2
Malaria
2
TB
2
Communicable Diseases
1
Clinical Training
1
Hepatitis
1
Public Health
1
Disaster Preparedness
1
Bacteriology
1
Cancer
1
Vector Control
1
Palliative Care
1
Infection Control & Prevention (IPC)
1
Yersinia pestis (Plague)
1
Countries
1
Yellow Fever
1
Policies
1
Information, Education and Communication (IEC)
1
Capacity Building
1
Humanitarian Crisis
1
Statistics
1
COPD/Asthma
1
Gynaecology & Obstetrics
1
Leishmaniasis
1
Laboratory Technologies
1
HIV & STI
1
Age & Elderly
1
Toolboxes
Clinical Guidelines
17
SARS-CoV-2 Variants
9
Inactivated COVID-19 Vaccines
7
Laboratory
6
Surveillance & Contact tracing
6
Genomic sequencing
6
Testing Guidelines
6
Surveillance
5
Public Health
5
Treatment Guidelines
5
Essential Medicines & Devices Lists
5
Laboratory Guidance
4
Immunization Guidelines
4
Vaxzevria (Astra Zeneca)
4
Outbreak Prevention & Control
3
Clinical Aspects, Treatment & Prevention
3
Influenza Prevention & Control
3
Research
3
Prevention & Preparedness
3
Clinical Aspects
3
Diagnostics & Laboratory Guidance
3
Country specific documents
3
Scientific & Research Studies
3
Covaxin
3
Clinical Aspects & Diagnostics
3
Disease Prevention & Control
3
Preparedness & Prevention
3
Ebola Prevention & Control
2
Influenza
2
Vaccination
2
Essential List
2
Training, others
2
Appeals and Response Plans
2
Global Impact: Socio-economic, health services, TB & HIV
2
Essential Medicines & Medical Devices
2
Fair Allocation & Ethical Aspects
2
COVAX Initiative
2
Moderna
2
Biontech/Pfizer Comirnaty
2
Infectious Diseases
2
MPOX - Monkeypox
2
Health Financing Toolbox
2
Alzheimer's Disease & Dementia
2
Antiretroviral Treatment ART
2
Meningitis & Encephalitis
2
Drugs
1
ART Drug Resistance
1
Treatment & Prevention
1
Vaccines & Immunization
1
Yellow Fever
1
Clinical Guidelines
1
Country specific
1
Key Resources
1
Children & Adolescents
1
Plague
1
Drug resistance
1
Cholera Prevention & Control
1
Latin America
1
Ebola & Marburg
1
Ebola
1
Public Health
1
International
1
Climate & Health
1
Context & Facts
1
Situation Reports & Updates
1
Research & Development
1
Studies
1
Public Health
1
Risk Communication & Community Engagement
1
For General Public & Community
1
For Health Worker
1
Oxygen Therapy
1
Situation Reports COVID-19
1
Access & Strategy
1
Vaccine Candidates & Research
1
Non-pharmaceutical interventions (NPIs)
1
Presentation
1
Long COVID/ Post-COVID Syndrome
1
Vector-based Vacines General
1
Johnson & Johnson
1
Research & Pipeline
1
Essential Medicines
1
Quality Assurance
1
General documents One Health
1
Guidelines & Manuals
1
Zoonoses
1
Health Impact & Climate Change
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Access to treatment and laboratory
1
General Information & Methodology
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Prevention & Strategies
1
Clinical Guidelines
1
Neurological Disorders
1
Zika
1
Diarrhoea
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Clinical Guidelines
1
Laboratory
1
Context & Facts
1
Chikungunya
1
Laboratory & Diagnostics
1
Action Plans, Policies & Response
1
AMR
1
Public Health
1
Plague Prevention & Control
1
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Accessed Nov. 28,2016
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
16.7.2021
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Poster, 4 Janaury 2022
Updated Treatment Guidelines
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac...
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Traitements contre la maladie à virus Ebola
recommended
Cette première version des orientations evolutives relatives a la prise en charge clinique de la MVE contient quatre nouvelles recommandations concernant l’utilisation de traitements contre la MVE, y compris deux recommandations fortes en faveur de l’utilisation de thérapies à base d’antico...
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the M...
Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with 3 species (L. donovani, L. infantum, and...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
